These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20387098)

  • 1. Prediction of the corneal permeability of drug-like compounds.
    Kidron H; Vellonen KS; del Amo EM; Tissari A; Urtti A
    Pharm Res; 2010 Jul; 27(7):1398-407. PubMed ID: 20387098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal and conjunctival drug permeability: Systematic comparison and pharmacokinetic impact in the eye.
    Ramsay E; Del Amo EM; Toropainen E; Tengvall-Unadike U; Ranta VP; Urtti A; Ruponen M
    Eur J Pharm Sci; 2018 Jul; 119():83-89. PubMed ID: 29625211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational prediction of oral drug absorption based on absorption rate constants in humans.
    Linnankoski J; Mäkelä JM; Ranta VP; Urtti A; Yliperttula M
    J Med Chem; 2006 Jun; 49(12):3674-81. PubMed ID: 16759110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of corneal permeability using artificial neural networks.
    Agatonovic-Kustrin S; Evans A; Alany RG
    Pharmazie; 2003 Oct; 58(10):725-9. PubMed ID: 14609285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico model of drug permeability across sublingual mucosa.
    Goswami T; Kokate A; Jasti BR; Li X
    Arch Oral Biol; 2013 May; 58(5):545-51. PubMed ID: 23123066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico prediction of drug permeability across buccal mucosa.
    Kokate A; Li X; Williams PJ; Singh P; Jasti BR
    Pharm Res; 2009 May; 26(5):1130-9. PubMed ID: 19184372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MI-QSAR models for prediction of corneal permeability of organic compounds.
    Chen C; Yang J
    Acta Pharmacol Sin; 2006 Feb; 27(2):193-204. PubMed ID: 16412269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative and qualitative prediction of corneal permeability for drug-like compounds.
    Ghorbanzad'e M; Fatemi MH; Karimpour M; Andersson PL
    Talanta; 2011 Oct; 85(5):2686-94. PubMed ID: 21962703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A corneal-PAMPA-based in silico model for predicting corneal permeability.
    Vincze A; Dargó G; Rácz A; Balogh GT
    J Pharm Biomed Anal; 2021 Sep; 203():114218. PubMed ID: 34166924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-silico prediction of blood-brain barrier permeability.
    Yan A; Liang H; Chong Y; Nie X; Yu C
    SAR QSAR Environ Res; 2013 Jan; 24(1):61-74. PubMed ID: 23092117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability prediction based on molecular structure for a diverse series of drugs.
    Turner JV; Maddalena DJ; Agatonovic-Kustrin S
    Pharm Res; 2004 Jan; 21(1):68-82. PubMed ID: 14984260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fully computational model for predicting percutaneous drug absorption.
    Neumann D; Kohlbacher O; Merkwirth C; Lengauer T
    J Chem Inf Model; 2006; 46(1):424-9. PubMed ID: 16426076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the permeability of drugs and drug-like molecules from MI-QSAR and HQSAR studies.
    Shinde RN; Srikanth K; Sobhia ME
    J Mol Model; 2012 Mar; 18(3):947-62. PubMed ID: 21638045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method.
    Narayanan R; Gunturi SB
    Bioorg Med Chem; 2005 Apr; 13(8):3017-28. PubMed ID: 15781411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
    Winiwarter S; Bonham NM; Ax F; Hallberg A; Lennernäs H; Karlén A
    J Med Chem; 1998 Dec; 41(25):4939-49. PubMed ID: 9836611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the vitreal half-life of small molecular drug-like compounds.
    Kidron H; Del Amo EM; Vellonen KS; Urtti A
    Pharm Res; 2012 Dec; 29(12):3302-11. PubMed ID: 22777295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Novel Quantitative Structure-Activity Relationship Model to Accurately Predict Pulmonary Absorption and Replace Routine Use of the Isolated Perfused Respiring Rat Lung Model.
    Edwards CD; Luscombe C; Eddershaw P; Hessel EM
    Pharm Res; 2016 Nov; 33(11):2604-16. PubMed ID: 27401409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of corneal permeability using polar molecular surface areas.
    Fu XC; Liang WQ
    Pharmazie; 2001 Aug; 56(8):667. PubMed ID: 11534350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.